Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Research highlights on a notable retrovirus and a popular guardian gene.

Vogiatzi P, Mason PJ.

Cell Cycle. 2010 Dec 15;9(24):4786. doi: 10.4161/cc.9.24.14166. No abstract available.

2.

Skirmish between the mighty p53 protein and the complex retrovirus HIV-1.

Srinivasan A.

Cell Cycle. 2010 Dec 15;9(24):4784. doi: 10.4161/cc.9.24.14095. No abstract available.

PMID:
21248487
3.

Cdk9 phosphorylates p53 on serine 392 independently of CKII.

Claudio PP, Cui J, Ghafouri M, Mariano C, White MK, Safak M, Sheffield JB, Giordano A, Khalili K, Amini S, Sawaya BE.

J Cell Physiol. 2006 Sep;208(3):602-12.

PMID:
16741955
4.

Intracellular delivery of p53 fused to the basic domain of HIV-1 Tat.

Ryu J, Lee HJ, Kim KA, Lee JY, Lee KS, Park J, Choi SY.

Mol Cells. 2004 Apr 30;17(2):353-9.

5.

Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.

Bulavin DV, Kovalsky O, Hollander MC, Fornace AJ Jr.

Mol Cell Biol. 2003 Jun;23(11):3859-71.

7.

CDK9 phosphorylates p53 on serine residues 33, 315 and 392.

Radhakrishnan SK, Gartel AL.

Cell Cycle. 2006 Mar;5(5):519-21. Epub 2006 Mar 1.

PMID:
16552184
8.

Retroviral microRNAs.

Harwig A, Das AT, Berkhout B.

Curr Opin Virol. 2014 Aug;7:47-54. doi: 10.1016/j.coviro.2014.03.013. Epub 2014 Apr 23. Review.

PMID:
24769093
9.

p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Yoon CH, Kim SY, Byeon SE, Jeong Y, Lee J, Kim KP, Park J, Bae YS.

J Virol. 2015 Apr;89(8):4262-80. doi: 10.1128/JVI.03087-14. Epub 2015 Feb 4.

10.

Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ.

Wang TJ, Huang MS, Hong CY, Tse V, Silverberg GD, Hsiao M.

Biochem Biophys Res Commun. 2001 Sep 14;287(1):173-80.

PMID:
11549271
11.

The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.

Albert TK, Antrecht C, Kremmer E, Meisterernst M.

PLoS One. 2016 Jan 8;11(1):e0146648. doi: 10.1371/journal.pone.0146648. eCollection 2016.

12.

Induction of apoptosis in p53-deficient human hepatoma cell line by wild-type p53 gene transduction: inhibition by antioxidant.

Lee KH, Kim KC, Jung YJ, Ham YH, Jang JJ, Kwon H, Sung YC, Kim SH, Han SK, Kim CM.

Mol Cells. 2001 Aug 31;12(1):17-24.

13.
14.

Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.

Thakur BK, Chandra A, Dittrich T, Welte K, Chandra P.

Biochem Biophys Res Commun. 2012 Jul 27;424(2):245-50. doi: 10.1016/j.bbrc.2012.06.084. Epub 2012 Jun 23.

PMID:
22732402
16.

Inhibition of β-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells.

Verma S, Ali A, Arora S, Banerjea AC.

Blood. 2011 Jun 16;117(24):6600-7. doi: 10.1182/blood-2011-01-333427. Epub 2011 Apr 26.

17.

Self-deleting suicide vectors (SDSV): selective killing of p53-deficient cancer cells.

Andreú T, Ebensperger C, Westphal EM, Klenner T, Stewart AF, Westhof A, Müller P, Knaus R, von Melchner H.

Cancer Res. 2001 Sep 15;61(18):6925-30.

18.

[Comparative analysis of herpes simplex virus thymidine kinase gene expression potentiation via HIV-1 Tat-TAR-system and cancer-specific promoters in p53(+) and p53(-) cells].

Mingaleeva RN, Chernov IP, Kopantsev EP, Zavalova LL, Sass AV, Sverdlov ED.

Mol Biol (Mosk). 2010 May-Jun;44(3):507-14. Russian.

PMID:
20608175
19.

Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.

Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P.

J Virol. 2002 Mar;76(6):2692-702.

20.

Supplemental Content

Support Center